Cantex to Present at Upcoming Investor Conferences

Published: 14/03/2018
Cantex to Present at Upcoming Investor Conferences
Source: WWW.PRNEWSWIRE.COM

WESTON, Fla., March 14, 2018 /PRNewswire/ -- Cantex Pharmaceuticals, Inc. ("Cantex"), a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of cancer and other life-threatening disorders, today announced its Chief Executive Officer, Stephen...

Read more
Related news
Comment
FACEBOOK